热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　剂泰科技-P（07666）首挂上市，公告显示，每股定价10.5港元，共发行2.01亿股股份，每手500股，所得款项净额约为19.93亿港元。截至发稿，股价上涨175.05%，现报28.88港元，成交额13.90亿港元。

　　招股书显示，剂泰科技是一家AI纳米材料创新企业，致力于有效载荷在不同生命体中的递送与应用。公司核心平台NanoForge整合了大规模脂质库、人工智能基础模型、METiS智能体、量子化学与分子动力学模拟及AI驱动高通量筛选平台，并在此基础上开发AiTEM、AiLNP及AiRNA三大解决方案，用于先进纳米材料及相关有效载荷的设计、优化与验证。

　　管线方面，剂泰科技已布局超过10款产品，覆盖中枢神经、肿瘤、免疫、代谢等方向。其中，MTS-004为公司进展较快的候选产品。公开资料显示，该产品用于假性延髓情绪失控相关治疗方向，并已完成III期临床研究主要终点；公司还通过产品授权和平台合作推进商业化验证。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.